179 related articles for article (PubMed ID: 16171526)
1. Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Lopez-Graniel C; Dolores R; Cetina L; Gonzalez A; Cantu D; Chanona J; Uribe J; Candelaria M; Brom R; de la Garza J; Duenas-Gonzalez A
BMC Cancer; 2005 Sep; 5():118. PubMed ID: 16171526
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
[TBL] [Abstract][Full Text] [Related]
3. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
4. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer.
Heath OM; Bryan SJ; Sohaib A; Barton DPJ
J Obstet Gynaecol; 2021 Nov; 41(8):1252-1256. PubMed ID: 33646894
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.
Andikyan V; Khoury-Collado F; Sandadi S; Tew WP; O'Cearbhaill RE; Konner JA; Sonoda Y; Barakat RR; Chi DS; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Jun; 23(5):923-8. PubMed ID: 23698798
[TBL] [Abstract][Full Text] [Related]
8. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
9. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer.
Murata S; Onozawa S; Sugihara F; Sakamoto A; Ueda T; Yamaguchi H; Yasui D; Mine T; Kumita S
Ann Surg Oncol; 2015 Nov; 22(12):3981-9. PubMed ID: 25758191
[TBL] [Abstract][Full Text] [Related]
11. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
[TBL] [Abstract][Full Text] [Related]
13. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
Kanao H; Aoki Y; Hisa T; Takeshima N
Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
[TBL] [Abstract][Full Text] [Related]
14. [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
Sardain H; Lavoué V; Foucher F; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2016 Apr; 45(4):315-29. PubMed ID: 26874666
[TBL] [Abstract][Full Text] [Related]
15. Single agent versus combination chemotherapy in recurrent cervical cancer.
Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V
J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235
[TBL] [Abstract][Full Text] [Related]
16. Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.
Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mantini G; Margariti PA; Ferrandina G; Scambia G
Tumori; 2005; 91(4):295-301. PubMed ID: 16277092
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
19. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases].
Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M
Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298
[TBL] [Abstract][Full Text] [Related]
20. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
Chen M; Pan L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
